Skip to main content
. 2022 Jul 16;22:35. doi: 10.1186/s40644-022-00474-2

Table 3.

Prognostic prediction models for the outcomes of patients with locally advanced cervical squamous cell cancer

Prediction Models Training Testing
Wald Test P-value C-index Wald Test P-value C-index
Progression-free survival
 2018 FIGO staging system 20.83 <0.001 0.657 10.82 0.001 0.677
 Clinical model 33.57 <0.001 0.731 15.94 <0.001 0.725
 Rad-PFS 40.17 <0.001 0.764 13.62 <0.001 0.762
 Combined model 50.67 <0.001 0.792 21.28 <0.001 0.809
Overall survival
 2018 FIGO staging system 12.54 <0.001 0.665 5.54 0.02 0.633
 Clinical model 22.53 <0.001 0.708 5.96 0.01 0.693
 Rad-OS 23.97 <0.001 0.793 12.72 <0.001 0.750
 Combined model 31.59 <0.001 0.822 13.43 <0.001 0.785

PFS progression-free survival, OS overall survival, FIGO Federation of Gynecology and Obstetrics.

HHS Vulnerability Disclosure